Internal Medicine, Cardiovascular Disease · Tracy, CA
NPI
1881632263
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1530 Bessie Ave, #101
Tracy, CA, 95376
Phone (209) 832-0343
Groups this clinician bills Medicare through
Medicare paid, 2024
$965K
13,960 services
Medicare patients, 2024
1,707
Average age 76
Drug cost, 2024
$4.6M
12,855 prescriptions
Company payments, 2025
$57K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajiv H Punjya was code 99490 (chronic, principal, and transitional care management), 1,496 times for 285 patients. In total Rajiv H Punjya billed 13,960 services in 76 codes, and Medicare paid $965K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,496 | 285 | $50.00 | $75K |
| 99454 E&M - Miscellaneous | Office | 1,451 | 226 | $38.50 | $56K |
| 99214 Office E&M - Established | Office | 1,358 | 895 | $98.22 | $133K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,281 | 265 | $38.41 | $49K |
| 99457 E&M - Miscellaneous | Office | 1,159 | 222 | $35.42 | $41K |
| 93000 Electrocardiogram | Office | 987 | 667 | $10.48 | $10K |
| 99215 Office E&M - Established | Office | 582 | 411 | $106.17 | $62K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 472 | 116 | $4.86 | $2,296 |
| 99233 Hospital E&M - Subsequent | Facility | 213 | 91 | $92.94 | $20K |
| 93306 Echocardiography (TTE/TEE) | Office | 209 | 206 | $151.29 | $32K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 182 | 90 | $407.87 | $74K |
| 93229 Electrocardiogram | Office | 171 | 151 | $683.15 | $117K |
| 93228 Electrocardiogram | Office | 171 | 151 | $18.16 | $3,105 |
| 93356 Echocardiography (TTE/TEE) | Office | 161 | 160 | $29.66 | $4,775 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 129 | 128 | $147.69 | $19K |
By year: 2022 $1.1M for 12,714 services; 2023 $1.1M for 14,240 services; 2024 $965K for 13,960 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 63 | 23 | $3.60 | $227 |
Medicare prescription drug claims, 2024
In 2024, the drug Rajiv H Punjya prescribed most often to Medicare patients was Ezetimibe, with 1,280 prescriptions and refills. In total Rajiv H Punjya wrote 12,855 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 1,280 | 3,580 | 437 | $42K |
| Atorvastatin Calcium Generic | 1,063 | 3,060 | 350 | $13K |
| Jardiance Empagliflozin | 725 | 1,663 | 248 | $905K |
| Carvedilol Generic | 705 | 2,003 | 229 | $7,495 |
| Losartan Potassium Generic | 633 | 1,760 | 218 | $8,989 |
| Metoprolol Succinate Generic | 583 | 1,646 | 212 | $9,783 |
| Eliquis Apixaban | 559 | 1,156 | 153 | $644K |
| Xarelto Rivaroxaban | 556 | 1,243 | 159 | $674K |
| Amlodipine Besylate Generic | 523 | 1,508 | 177 | $4,110 |
| Rosuvastatin Calcium Generic | 504 | 1,423 | 163 | $13K |
| Clopidogrel Clopidogrel Bisulfate | 437 | 1,230 | 162 | $5,577 |
| Farxiga Dapagliflozin Propanediol | 335 | 759 | 99 | $399K |
| Spironolactone Generic | 275 | 759 | 94 | $2,947 |
| Furosemide Generic | 196 | 521 | 85 | $1,434 |
| Lisinopril Generic | 189 | 547 | 68 | $1,152 |
Brand drugs: 3,545 claims; generic drugs: 9,310 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajiv H Punjya $57K ($57K in general payments such as food, travel and fees) from 26 companies. The largest payer was Novo Nordisk Inc with $40K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 27 | $40K |
| Lilly USA, LLC LLY | 26 | $10K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $3,642 |
| Alnylam Pharmaceuticals Inc. ALNY | 7 | $382 |
| Merck Sharp & Dohme LLC MRK | 11 | $357 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $343 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $308 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $274 |
| Boston Scientific Corporation BSX | 7 | $235 |
| BridgeBio Pharma, Inc. BBIO | 4 | $222 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.